Searchable abstracts of presentations at key conferences in endocrinology

ea0081p101 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Hypothyroidism and obesity in a population of Italian women with lipedema and correlation with the clinical stage

Patton Laura , Ricolfi Lorenzo

Aim: Lipedema is a painful fat disorder that affects ~11% of the female population, characterized by bilateral, disproportionate accumulation of subcutaneous adipose tissue predominantly in the lower body. The initial manifestations of lipedema arise in phases of hormonal change (puberty, pregnancy, menopause). The pathophysiology of lipedema is unclear. The putative causes proposed include altered adipogenesis, microangiopathy, and disturbed lymphatic microcirculation The dis...

ea0090ep316 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Pain in lipedema: proposal for clinical evaluation and correlation with clinical aspects, anthropometric measurements and hormonal profile

Patton Laura , Ricolfi Lorenzo , Bortolon Micaela

Aim: Lipedema is a painful fat disorder that affects 11-17% of woman. The diagnosis is based on typical clinical features: bilateral symmetrical disproportionate fatty tissue hypertrophy on the limbs sparing of the hands and feet, feeling of heaviness and tension, easy bruising, transient edema and pain in the affected areas. There are three clinical stages (1, 2 and 3) that refer primarily to appearance of the skin, texture of subdermal tissue and the presenc...

ea0029p1051 | Male Reproduction | ICEECE2012

Ten years of EAA/EMQN quality control scheme for microdeletions of the Y chromosome

Tuttelmann F. , Hoefsloot L. , Patton S. , Simoni M. , Krausz C.

Introduction: Y-chromosomal azoospermia factor (AZF) microdeletions are one of the few well-established genetic causes of male infertility, specifically azoospermia or severe oligozoospermia. Since the introduction of a PCR-based method to easily detect the distinct deletion patterns, the screening of infertile men for Y microdeletions has become a very common genetic test performed frequently by a large number of laboratories. An external quality control scheme was establishe...

ea0016p141 | Clinical cases | ECE2008

Monogenic form of polycystic ovary syndrome due to mutation in lamin A/C gene: case report of two sisters

Forlani Giulia , Gambineri Alessandra , Patton Laura , Pagotto Uberto , Pasquali Renato

We report of two sisters with hyperandrogenism, menstrual abnormalities, and severe insulin resistance. The elder sister was seen after puberty at age 21 and she was referred for the evaluation of hirsutism and polymenorrhoea; the younger was seen earlier in life, at age 15, for the evaluation of secondary amenorrhoea. In both of them, we performed the diagnosis of polycystic ovary syndrome (PCOS) in accordance to the Rotterdam criteria. They also presented a lipodystrophic ph...

ea0011p740 | Steroids | ECE2006

Long-term effect of flutamide, metformin and their combination in dieting obese women with polycystic ovary syndrome

Gambineri A , Patton L , Vaccina A , Pagotto U , Pasquali R

Tissue inflammation is usually transient but in diseases such as rheumatoid arthritis (RA) inflammation persists. It remains unclear why inflammation persists in some tissues and not in others. Recent studies have shown that stromal cells such as fibroblasts play a pivotal role in determining this persisitance. We have hypothesized that glucocorticoid (GC) activation via the enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) within fibroblasts plays a key role in ...

ea0016p620 | Reproduction | ECE2008

Basal INSL3 levels predict LH and androgen response to GnRH analogue in PCOS women

Patton Laura , Gambineri Alessandra , De Iasio Rosaria , Fanelli Flaminia , Pasquali Renato

In a previous study, we demonstrated that the concept of functional ovarian hyperandrogenism (FOH), as documented by the exaggerated 17OHP response to buserelin (GnRH-analogue) does not represent a specific feature of all women with PCOS, being present in less than half of PCOS and is a condition characterized by more severe hyperandrogenemia, glucose-stimulated B-cell insulin secretion and worse insulin resistance. INSL3 is produced in the Leydig cells and at reduced levels i...

ea0016p639 | Reproduction | ECE2008

Weight loss determines a complete remission of the polycystic ovary syndrome in most of obese women

Grassi Ilaria , Giovannini Lara , Forlani Giulia , Patton Laura , Gambineri Alessandra , Pasquali Renato

Obesity is strictly connected with Polycystic Ovary Syndrome (PCOS). However, we still do not know whether a form of PCOS secondary to obesity exists or whether obesity exacerbates manifestations of the syndrome. To answer this question we contacted seventy obese patients with PCOS that attended our Endocrinology Unit in the last 3 years and that lose weight after at least 6 months of dietary treatment. Sixty-five out of 70 patients agreed to take part to the study and gave th...

ea0014p246 | (1) | ECE2007

Hyperactivity of the hypothalamic-pituitary-axis and adrenal hyperandrogenism in polycystic ovary syndrome: a consequence of 5 β-reductase hyperfunction

Gambineri Alessandra , Patton Laura , Forlani Giulia , Munarini Alessandra , Tomassoni Federica , Pagotto Uberto , Pasquali Renato

Among the uncertainties surrounding the etiology of polycystic ovary syndrome (PCOS) the role of increased peripheral cortisol metabolism has become interesting, particularly in relationship to the pathogenesis of adrenal hyperandrogenism. The patways of cortisol metabolism include irreversible inactivation of cortisol by 5α- and 5β-reductase. To evaluate the association of 5α- and 5β-reductase activity with adrenal hyperandrogenism in PCOS, we recruited 90...

ea0014p259 | (1) | ECE2007

Prevalence of metabolic syndrome in a cohort of young Mediterranean women with polycystic ovary syndrome and association with clinical and biochemical parameters

Patton Laura , Gambineri Alessandra , Repaci Andrea , Forlani Giulia , Pagotto Uberto , Pasquali Renato

Aim: The purpose of the study was to evaluate the prevalence of the metabolic syndrome (MS) in a cohort of young Mediterranean women with PCOS in reproductive age and to evaluate the association of the MS with clinical and biochemical parameters.Setting: Among 200 PCOS (17-31 years) criteria of MS in accordance with the “NCEP-ATPIII” were used to construct 3 groups: no one criteria, 1 or 2 criteria and 3 or more criteria (affected by MS). All p...

ea0011p769 | Steroids | ECE2006

Insulin-Like Factor 3: a new circulating marker for the polycystic ovary syndrome-type of ovarian dysfunction

Pasquali R , Patton L , Vaccina A , De Iasio R , Pagotto U , Gambineri A

Insulin-like factor 3 (INSL3), a member of the relaxin-insulin family, is produced in the Leydig cells and at reduced levels in ovarian thecal cells. As ovaries from most of PCOS are characterized by an hyperplasia of the theca interna, we hypothesized that INSL3 could be overproduced in PCOS women and therefore that circulating levels of this hormone could became a new marker for the syndrome. Forty lean and obese women with PCOS and 20 controls comparable for age and weight ...